Atlas Trials

Recurrent Salivary Gland Carcinoma

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Recurrent Salivary Gland Carcinoma

RecordFirmDate
Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer (NCT04576091)National Cancer Institute (NCI)2022-07-06
Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer (NCT03146650)Northwestern University2017-05-19
Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery (NCT02538510)University of Washington2015-10-08
Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma (NCT01604772)National Cancer Institute (NCI)2012-07-23
Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer (NCT01254617)National Cancer Institute (NCI)2011-02-10
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy (NCT01256385)National Cancer Institute (NCI)2010-11-01
Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (NCT01175980)National Cancer Institute (NCI)2010-08-06
Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer (NCT00954226)M.D. Anderson Cancer Center2009-08-05
Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors (NCT00859937)National Cancer Institute (NCI)2009-03-16
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT00588770)National Cancer Institute (NCI)2008-08-08
Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer (NCT00458978)National Cancer Institute (NCI)2007-02-01

Track Recurrent Salivary Gland Carcinoma automatically

Every clearance here is in the API, with alerts when new ones post.